{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T11:54:16Z","timestamp":1782820456918,"version":"3.54.5"},"reference-count":151,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Department of Biotechnology","award":["BT\/PR\/50633\/MED\/32\/975\/2023"],"award-info":[{"award-number":["BT\/PR\/50633\/MED\/32\/975\/2023"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Diagn Ther"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s40291-026-00851-8","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T14:57:16Z","timestamp":1779202636000},"page":"629-650","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Heat Shock Proteins as Cancer Biomarkers: From Mechanism to Clinical Application"],"prefix":"10.1007","volume":"30","author":[{"given":"Prajjwal","family":"Kushwaha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1120-444X","authenticated-orcid":false,"given":"Ipsita","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"key":"851_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02439-w","volume":"10","author":"OF Kuzu","year":"2025","unstructured":"Kuzu OF, Granerud LJ, Saatcioglu F. Navigating the landscape of protein folding and proteostasis: from molecular chaperones to therapeutic innovations. Signal Transduct Target Ther. 2025;10:358.","journal-title":"Signal Transduct Target Ther"},{"key":"851_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2023.168418","volume":"436","author":"LM Hendershot","year":"2024","unstructured":"Hendershot LM, Buck TM, Brodsky JL. The essential functions of molecular chaperones and folding enzymes in maintaining endoplasmic reticulum homeostasis. J Mol Biol. 2024;436:168418.","journal-title":"J Mol Biol"},{"key":"851_CR3","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/s41392-025-02166-2","volume":"10","author":"J Gu","year":"2025","unstructured":"Gu J, He Y, He C, Zhang Q, Huang Q, Bai S, et al. Advances in the structures, mechanisms and targeting of molecular chaperones. Signal Transduct Target Ther. 2025;10:84.","journal-title":"Signal Transduct Target Ther"},{"key":"851_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2025.1491227","volume":"12","author":"XH Makhoba","year":"2025","unstructured":"Makhoba XH. Two sides of the same coin: heat shock proteins as biomarkers and therapeutic targets for some complex diseases. Front Mol Biosci. 2025;12:1491227.","journal-title":"Front Mol Biosci"},{"key":"851_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2025.130395","volume":"129","author":"A Gutierrez","year":"2025","unstructured":"Gutierrez A, Archdeacon J, Blagg BS. TRAP1 and its therapeutic potential. Bioorg Med Chem Lett. 2025;129:130395.","journal-title":"Bioorg Med Chem Lett"},{"issue":"2","key":"851_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/cells9030587","volume":"9","author":"Z Albakova","year":"2020","unstructured":"Albakova Z, Armeev GA, Kanevskiy LM, Kovalenko EI, Sapozhnikov AM. HSP70 multi-functionality in cancer. Cells. 2020;9(2):587.","journal-title":"Cells"},{"key":"851_CR7","doi-asserted-by":"publisher","first-page":"4069","DOI":"10.1007\/s00018-021-03764-3","volume":"78","author":"L Secl\u00ec","year":"2021","unstructured":"Secl\u00ec L, Fusella F, Avalle L, Brancaccio M. The dark-side of the outside: how extracellular heat shock proteins promote cancer. Cell Mol Life Sci. 2021;78:4069\u201383.","journal-title":"Cell Mol Life Sci"},{"key":"851_CR8","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1007\/s12013-025-01724-3","volume":"83","author":"B Kumari","year":"2025","unstructured":"Kumari B. Cellular stress responses and associated diseases: a focus on heat shock proteins. Cell Biochem Biophys. 2025;83:2793\u2013804.","journal-title":"Cell Biochem Biophys"},{"key":"851_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-84834-x","volume":"15","author":"W Liao","year":"2025","unstructured":"Liao W, Huang M, Du X, Tang L, Li J, Tang Q. Comprehensive analysis of HSP110, 90, 70, 60 families and tumor immune microenvironment characterization in clear cell renal cell carcinoma. Sci Rep. 2025;15:469.","journal-title":"Sci Rep"},{"key":"851_CR10","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000024274","volume":"100","author":"W Lu","year":"2021","unstructured":"Lu W, Wang Y, Gan M, Duan Q. Prognosis and predictive value of heat-shock proteins expression in oral cancer: a PRISMA-compliant meta-analysis. Medicine. 2021;100:e24274.","journal-title":"Medicine"},{"key":"851_CR11","doi-asserted-by":"publisher","first-page":"1067179","DOI":"10.3389\/fonc.2023.1067179","volume":"13","author":"Y Zhuang","year":"2023","unstructured":"Zhuang Y, Zhang F, Xu Y, He L, Huang W, Hong C, et al. Evaluating the expression of HSP27 and topoisomerase II \u03b1 in a retrospective cohort of patients diagnosed with locally advanced breast cancer and treated with neoadjuvant anthracycline-based chemotherapies. Front Oncol. 2023;13:1067179.","journal-title":"Front Oncol"},{"key":"851_CR12","doi-asserted-by":"publisher","first-page":"837","DOI":"10.5603\/GP.a2021.0061","volume":"92","author":"P Bodzek","year":"2021","unstructured":"Bodzek P, Damasiewicz-Bodzek A, Janosz I, Witek L, Olejek A. HSP27 in patients with ovarian cancer. Ginekol Polska. 2021;92:837\u201343.","journal-title":"Ginekol Polska"},{"key":"851_CR13","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1111\/IGC.0b013e3181bf425b","volume":"19","author":"A Olejek","year":"2009","unstructured":"Olejek A, Damasiewicz-Bodzek A, Bodzek P, Wielkoszy\u0144ski T, Zam\u0142y\u0144ski J, Sto\u0142tny P, et al. Concentrations of antibodies against QCM and SAW gas and VOC sensors based on metal oxide composites (principles, fabrication, sensing materials and performances) HSP27 in the sera of women with ovarian carcinoma. Int J Gynecol Cancer. 2009;19:1516\u201320.","journal-title":"Int J Gynecol Cancer"},{"key":"851_CR14","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/jcmm.12444","volume":"19","author":"Y Guo","year":"2015","unstructured":"Guo Y, Ziesch A, Hocke S, Kampmann E, Ochs S, de Toni EN, et al. Overexpression of HSP27 increases gemcitabine sensitivity in pancreatic cancer cells through S-phase arrest and apoptosis. Cell Mol Med. 2015;19:340\u201350.","journal-title":"Cell Mol Med"},{"key":"851_CR15","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.121647","volume":"21","author":"CH Ahn","year":"2025","unstructured":"Ahn CH, Park JE, Sim DY, Park SY, Cha HJ, Shim BS, et al. STK32C as a therapeutic target in colorectal cancer via HSP90-PI3K\/AKT\/mTOR signaling. Int J Biol Sci. 2025;21:6215.","journal-title":"Int J Biol Sci"},{"key":"851_CR16","doi-asserted-by":"publisher","first-page":"881","DOI":"10.3892\/ijmm.2015.2274","volume":"36","author":"G Kuroyanagi","year":"2015","unstructured":"Kuroyanagi G, Tokuda H, Yamamoto N, Matsushima-Nishiwaki R, Kozawa O, Otsuka T. Unphosphorylated HSP27 (HSPB1) regulates the translation initiation process via a direct association with eIF4E in osteoblasts. Int J Mol Med. 2015;36:881\u20139.","journal-title":"Int J Mol Med"},{"key":"851_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-021-01990-4","volume":"21","author":"X Wang","year":"2021","unstructured":"Wang X, Xie L, Zhu L. Clinicopathological significance of HSP70 expression in gastric cancer: a systematic review and meta-analysis. BMC Gastroenterol. 2021;21:437.","journal-title":"BMC Gastroenterol"},{"key":"851_CR18","doi-asserted-by":"publisher","DOI":"10.5455\/aim.2018.26.160-163","volume":"26","author":"F Yusuf","year":"2018","unstructured":"Yusuf F, Adewiah S, Fatchiyah F. The level short chain fatty acids and HSP70 in colorectal cancer and non-colorectal cancer. Acta Inform Med. 2018;26:160.","journal-title":"Acta Inform Med"},{"key":"851_CR19","doi-asserted-by":"publisher","first-page":"681","DOI":"10.18632\/oncotarget.28764","volume":"16","author":"K Kwong","year":"2025","unstructured":"Kwong K, Pan Y, Morales J, Watson M, Allegakoen DV, Lee AG, et al. In vivo manipulation of the protein homeostasis network in rhabdomyosarcoma. Oncotarget. 2025;16:681\u201396.","journal-title":"Oncotarget"},{"key":"851_CR20","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.7150\/ijbs.77979","volume":"19","author":"C Zhou","year":"2023","unstructured":"Zhou C, Yu T, Zhu R, Lu J, Ouyang X, Zhang Z, et al. Timosaponin AIII promotes non-small-cell lung cancer ferroptosis through targeting and facilitating HSP90 mediated GPX4 ubiquitination and degradation. Int J Biol Sci. 2023;19:1471\u201389.","journal-title":"Int J Biol Sci"},{"key":"851_CR21","doi-asserted-by":"publisher","first-page":"2932","DOI":"10.1158\/0008-5472.CAN-06-4511","volume":"67","author":"E Pick","year":"2007","unstructured":"Pick E, Kluger Y, Giltnane JM, Moeder C, Camp RL, Rimm DL, et al. High HSP90 expression is associated with decreased survival in breast cancer. Cancer Res. 2007;67:2932\u20137.","journal-title":"Cancer Res"},{"key":"851_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14174187","volume":"14","author":"M Alalem","year":"2022","unstructured":"Alalem M, Bhosale M, Ranjan A, Yamamoto S, Kaida A, Nishikawa S, et al. Mutant p53 depletion by novel inhibitors for HSP40\/J-domain proteins derived from the natural compound plumbagin. Cancers. 2022;14:4187.","journal-title":"Cancers"},{"key":"851_CR23","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.3390\/ph5091008","volume":"5","author":"F Zagouri","year":"2012","unstructured":"Zagouri F, Bournakis E, Koutsoukos K, Papadimitriou CA. HSP90 expression and breast cancer. Pharmaceuticals. 2012;5:1008\u201320.","journal-title":"Pharmaceuticals"},{"key":"851_CR24","doi-asserted-by":"publisher","first-page":"881","DOI":"10.2217\/bmm-2018-0155","volume":"12","author":"M Kasanga","year":"2018","unstructured":"Kasanga M, Liu L, Xue L, Song X. Serum HSP90\u03b1 have an advantage in diagnosis of colorectal cancer at early stage. Biomark Med. 2018;12:881\u201390.","journal-title":"Biomark Med"},{"key":"851_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10112747","volume":"10","author":"Z Albakova","year":"2022","unstructured":"Albakova Z, Mangasarova Y, Sapozhnikov A. Impaired heat shock protein expression in activated T cells in B-cell lymphoma. Biomedicines. 2022;10:2747.","journal-title":"Biomedicines"},{"key":"851_CR26","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12943-025-02226-9","volume":"24","author":"L Luo","year":"2025","unstructured":"Luo L, Yang P, Mastoraki S, Rao X, Wang Y, Kettner NM, et al. Single-cell RNA sequencing identifies molecular biomarkers predicting late progression to CDK4\/6 inhibition in patients with HR+\/HER2- metastatic breast cancer. Mol Cancer. 2025;24:48.","journal-title":"Mol Cancer"},{"key":"851_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.218233","volume":"639","author":"NK Horvat","year":"2025","unstructured":"Horvat NK, Diab M, Phillips MJ, Veal-McCook A, Grundy EE, Alese OB, et al. A phase Ib\/II trial of XL888 (HSP90 inhibitor) and pembrolizumab in metastatic pancreatic cancer with translational immune profiling. Cancer Lett. 2025;639:218233.","journal-title":"Cancer Lett"},{"key":"851_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1601243","volume":"16","author":"C Li","year":"2025","unstructured":"Li C, Lin X, Wang J, Zhou Q, Feng F, Xu J. Multi-omics-based subtyping of melanoma suggests distinct immune and targeted therapy strategies. Front Immunol. 2025;16:1601243.","journal-title":"Front Immunol"},{"key":"851_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.218010","volume":"633","author":"J Chen","year":"2025","unstructured":"Chen J, Vallega KA, Wang D, Bildtsen E, Fu H, Ramalingam SS, et al. Targeting MKK3\/c-Myc interaction to overcome osimertinib acquired resistance in EGFR mutant lung cancer. Cancer Lett. 2025;633:218010.","journal-title":"Cancer Lett"},{"key":"851_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07650-9","volume":"16","author":"Y Sui","year":"2025","unstructured":"Sui Y, Shen Z, Pan R, Ma R, Si R, Feng J, et al. AHSA1-HSP90AA1 complex stabilized IFI6 and TGFB1 promotes mitochondrial stability and EMT in EGFR-mutated lung adenocarcinoma under Osimertinib pressure. Cell Death Dis. 2025;16:298.","journal-title":"Cell Death Dis"},{"key":"851_CR31","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1007\/s10147-025-02782-6","volume":"30","author":"MV Shahana","year":"2025","unstructured":"Shahana MV, Choudhary B. HSP90 and the cancer transcriptome: a comprehensive review of inhibitors and mechanistic insights. Int J Clin Oncol. 2025;30:1294\u2013308.","journal-title":"Int J Clin Oncol"},{"key":"851_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26189130","volume":"26","author":"KR Karpiuk","year":"2025","unstructured":"Karpiuk KR, M\u0142ynarczyk G, Matowicka-Karna J, Darewicz B. Emerging biomarkers in urological cancers: angiogenesis and damage-associated molecular pattern signaling. Int J Mol Sci. 2025;26:9130.","journal-title":"Int J Mol Sci"},{"key":"851_CR33","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s12668-024-01639-y","volume":"15","author":"S Sadr","year":"2025","unstructured":"Sadr S, Rahdar A, Pandey S, Hajjafari A, Soroushianfar M, Sepahvand H, et al. Revolutionizing cancer detection: harnessing quantum dots and graphene-based nanobiosensors for lung and breast cancer diagnosis. BioNanoScience. 2025;15:17\u201329.","journal-title":"BioNanoScience"},{"key":"851_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-024-03260-5","volume":"24","author":"D Xiang","year":"2024","unstructured":"Xiang D, Fu L, Yang Y, Liu CJ, He Y. Evaluating the diagnostic accuracy of heat shock proteins and their combination with alpha-fetoprotein in the detection of hepatocellular carcinoma: a meta-analysis. BMC Gastroenterol. 2024;24:178.","journal-title":"BMC Gastroenterol"},{"key":"851_CR35","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1002\/hep.24237","volume":"53","author":"M Sherman","year":"2011","unstructured":"Sherman M, Bruix J. Alpha-fetoprotein should be included in the hepatocellular carcinoma surveillance guidelines of the American association for the study of liver diseases. Hepatology. 2011;53:1061\u20132.","journal-title":"Hepatology"},{"key":"851_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/cells14201627","volume":"14","author":"J Kabut","year":"2025","unstructured":"Kabut J, Soko\u0142owski J, \u017belazna W, St\u0119pie\u0144 M, Strauchman M, Jaworska N, et al. Heat shock proteins in pancreatic cancer: pathogenic mechanisms and clinical implications. Cells. 2025;14:1627.","journal-title":"Cells"},{"key":"851_CR37","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.humpath.2016.09.039","volume":"61","author":"S Chu","year":"2017","unstructured":"Chu S, Wen Q, Qing Z, Luo J, Wang W, Chen L, et al. High expression of HSP10 correlates negatively with estrogen\/progesterone receptor status and predicts poor prognosis in invasive ductal breast carcinoma. Hum Pathol. 2017;61:173\u201380.","journal-title":"Hum Pathol"},{"key":"851_CR38","doi-asserted-by":"publisher","first-page":"8219","DOI":"10.2147\/CMAR.S218427","volume":"11","author":"J Feng","year":"2019","unstructured":"Feng J, Zhan Y, Zhang Y, Zheng H, Wang W, Fan S. Increased expression of HSP10 and HSP70 correlates with poor prognosis of nasopharyngeal carcinoma. Cancer Manag Res. 2019;11:8219\u201327.","journal-title":"Cancer Manag Res"},{"key":"851_CR39","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3233\/CBM-200410","volume":"30","author":"Y Tang","year":"2021","unstructured":"Tang Y, Yang Y, Luo J, Liu S, Zhan Y, Zang H, et al. Overexpression of HSP10 correlates with HSP60 and Mcl-1 levels and predicts poor prognosis in non-small cell lung cancer patients. Cancer Biomark. 2021;30:85\u201394.","journal-title":"Cancer Biomark"},{"key":"851_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0185563","volume":"12","author":"W Fan","year":"2017","unstructured":"Fan W, Fan SS, Feng J, Xiao D, Fan S, Luo J. Elevated expression of HSP10 protein inhibits apoptosis and associates with poor prognosis of astrocytoma. PLoS ONE. 2017;12:e0185563.","journal-title":"PLoS ONE"},{"key":"851_CR41","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v7.i3.260","volume":"7","author":"HK S\u00f6derstr\u00f6m","year":"2019","unstructured":"S\u00f6derstr\u00f6m HK, Kauppi JT, Oksala N, Paavonen T, Krogerus L, R\u00e4s\u00e4nen J, et al. Overexpression of HSP27 and HSP70 is associated with decreased survival among patients with esophageal adenocarcinoma. World J Clin Cases. 2019;7:260.","journal-title":"World J Clin Cases"},{"key":"851_CR42","first-page":"953","volume":"3","author":"Z Yu","year":"2010","unstructured":"Yu Z, Zhi J, Peng X, Zhong X, Xu A. Clinical significance of HSP27 expression in colorectal cancer. Mol Med Rep. 2010;3:953\u20138.","journal-title":"Mol Med Rep"},{"key":"851_CR43","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.4161\/cc.5.22.3448","volume":"5","author":"C Garrido","year":"2006","unstructured":"Garrido C, Brunet M, Didelot C, Zermati Y, Schmitt E, Kroemer G. Heat shock proteins 27 and 70: anti-apoptotic proteins with tumorigenic properties. Cell Cycle. 2006;5:2592\u2013601.","journal-title":"Cell Cycle"},{"key":"851_CR44","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.hpb.2016.05.004","volume":"18","author":"W Petrushnko","year":"2016","unstructured":"Petrushnko W, Gundara JS, de Reuver PR, O\u2019Grady G, Samra JS, Mittal A. Systematic review of peri-operative prognostic biomarkers in pancreatic ductal adenocarcinoma. HPB. 2016;18:652\u201363.","journal-title":"HPB"},{"key":"851_CR45","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1111\/j.1582-4934.2011.01473.x","volume":"16","author":"C Sch\u00e4fer","year":"2012","unstructured":"Sch\u00e4fer C, Seeliger H, Bader DC, Assmann G, Buchner D, Guo Y, et al. Heat shock protein 27 as a prognostic and predictive biomarker in pancreatic ductal adenocarcinoma. J Cell Mol Med. 2012;16:1776\u201391.","journal-title":"J Cell Mol Med"},{"key":"851_CR46","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.pan.2013.10.005","volume":"13","author":"A Tsiaousidou","year":"2013","unstructured":"Tsiaousidou A, Lambropoulou M, Chatzitheoklitos E, Tripsianis G, Tsompanidou C, Simopoulos C, et al. B7H4, HSP27 and DJ-1 molecular markers as prognostic factors in pancreatic cancer. Pancreatology. 2013;13:564\u20139.","journal-title":"Pancreatology"},{"key":"851_CR47","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1007\/s00432-020-03175-0","volume":"146","author":"R Drexler","year":"2020","unstructured":"Drexler R, Wagner KC, K\u00fcchler M, Feyerabend B, Kleine M, Oldhafer KJ. Significance of unphosphorylated and phosphorylated heat shock protein 27 as a prognostic biomarker in pancreatic ductal adenocarcinoma. J Cancer Res Clin Oncol. 2020;146:1125\u201337.","journal-title":"J Cancer Res Clin Oncol"},{"key":"851_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/cells12101414","volume":"12","author":"R Crake","year":"2023","unstructured":"Crake R, Gasmi I, Dehaye J, Lardinois F, Peiffer R, Maloujahmoum N, et al. Resistance to gemcitabine in pancreatic cancer is connected to methylglyoxal stress and heat shock response. Cells. 2023;12:1414.","journal-title":"Cells"},{"key":"851_CR49","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1373\/clinchem.2006.079194","volume":"53","author":"C Melle","year":"2007","unstructured":"Melle C, Ernst G, Escher N, Hartmann D, Schimmel B, Bleul A, et al. Protein profiling of microdissected pancreas carcinoma and identification of HSP27 as a potential serum marker. Clin Chem. 2007;53:629\u201335.","journal-title":"Clin Chem"},{"key":"851_CR50","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.cca.2012.03.008","volume":"413","author":"M Zimmermann","year":"2012","unstructured":"Zimmermann M, Nickl S, Lambers C, Hacker S, Mitterbauer A, Hoetzenecker K, et al. Discrimination of clinical stages in non-small cell lung cancer patients by serum HSP27 and HSP70: a multi-institutional case-control study. Clin Chim Acta. 2012;413:1115\u201320.","journal-title":"Clin Chim Acta"},{"key":"851_CR51","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s12192-012-0377-8","volume":"18","author":"G Gruden","year":"2013","unstructured":"Gruden G, Carucci P, Lolli V, Cosso L, Dellavalle E, Rolle E, et al. Serum HSP27 levels in patients with hepatocellular carcinoma. Cell Stress Chaperones. 2013;18:235\u201341.","journal-title":"Cell Stress Chaperones"},{"key":"851_CR52","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1007\/s00432-025-06309-4","volume":"151","author":"J Borowczak","year":"2025","unstructured":"Borowczak J, \u0141aszczych D, Czy\u017cnikiewicz A, Marsza\u0142ek A, Szylberg \u0141, Bodnar M. Low expression of HSP27 and HSP70 predicts poor prognosis in laryngeal squamous cell carcinoma. J Cancer Res Clin Oncol. 2025;151:264.","journal-title":"J Cancer Res Clin Oncol"},{"key":"851_CR53","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3892\/mmr.2025.13521","volume":"31","author":"CL Li","year":"2025","unstructured":"Li CL, Yeh KY, Huang WN, Yen CY, Wang KC, Liao EC, et al. Brevilin A inhibits IL-17A induced inflammation in psoriasis by modulating HSP70. Mol Med Rep. 2025;31:156.","journal-title":"Mol Med Rep"},{"key":"851_CR54","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1080\/1061186X.2021.1920025","volume":"30","author":"B Sun","year":"2022","unstructured":"Sun B, Li G, Yu Q, Liu D, Tang X. HSP60 in cancer: a promising biomarker for diagnosis and a potentially useful target for treatment. J Drug Target. 2022;30:31\u201345.","journal-title":"J Drug Target"},{"key":"851_CR55","doi-asserted-by":"publisher","first-page":"4845","DOI":"10.1111\/j.1742-4658.2011.08385.x","volume":"278","author":"C Hamelin","year":"2011","unstructured":"Hamelin C, Cornut E, Poirier F, Pons S, Beaulieu C, Charrier JP, et al. Identification and verification of HSP60 as a potential serum marker for colorectal cancer. FEBS J. 2011;278:4845\u201359.","journal-title":"FEBS J"},{"key":"851_CR56","first-page":"6284","volume":"18","author":"M Vocka","year":"2019","unstructured":"Vocka M, Langer D, Fryba V, Petrtyl J, Hanus T, Kalousova M, et al. Novel serum markers HSP60, CHI3L1 and IGFBP-2 in metastatic colorectal cancer. Oncol Lett. 2019;18:6284\u201392.","journal-title":"Oncol Lett"},{"key":"851_CR57","first-page":"47","volume":"6","author":"ER Zaher","year":"2018","unstructured":"Zaher ER, Hemida MA, El-Hashash MM, El-Sheridy HG. Using a panel of heat shock proteins for diagnosis and prognosis of breast cancer. Cancer Res Treat. 2018;6:47\u201353.","journal-title":"Cancer Res Treat"},{"key":"851_CR58","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/S0171-2985(00)80091-1","volume":"201","author":"K Trieb","year":"2000","unstructured":"Trieb K, Gerth R, Windhager R, Grohs JG, Holzer G, Berger P, et al. Serum antibodies against the HSP60 are elevated in patients with osteosarcoma. Immunobiology. 2000;201:368\u201376.","journal-title":"Immunobiology"},{"key":"851_CR59","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/jso.21992","volume":"104","author":"X Xu","year":"2011","unstructured":"Xu X, Wang W, Shao W, Yin W, Chen H, Qiu Y, et al. HSP60 expression was significantly correlated with the prognosis of lung adenocarcinoma. J Surg Oncol. 2011;104:598\u2013603.","journal-title":"J Surg Oncol"},{"key":"851_CR60","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3390\/ijms20010131","volume":"20","author":"W Kim","year":"2019","unstructured":"Kim W, Ryu J, Kim JE. CCAR2\/DBC1 and HSP60 positively regulate expression of survivin in neuroblastoma cells. Int J Mol Sci. 2019;20:131.","journal-title":"Int J Mol Sci"},{"key":"851_CR61","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1080\/14737159.2017.1356230","volume":"17","author":"BC Caruso","year":"2017","unstructured":"Caruso BC, Cappello F, Macario AJ, Conway ME, Logozzi M, Fais S, et al. Exosomal HSP60: a potentially useful biomarker for diagnosis, assessing prognosis and monitoring response to treatment. Expert Rev Mol Diagn. 2017;17:815\u201322.","journal-title":"Expert Rev Mol Diagn"},{"key":"851_CR62","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4172\/2155-9899.1000264","volume":"5","author":"S Breuninger","year":"2014","unstructured":"Breuninger S, Erl J, Knape C, Gunther S, Regel I, R\u00f6del F, et al. Quantitative analysis of liposomal heat shock protein 70 (Hsp70) in the blood of tumor patients using a novel LipHsp70 ELISA. J Clin Cell Immunol. 2014;5:5.","journal-title":"J Clin Cell Immunol."},{"key":"851_CR63","doi-asserted-by":"publisher","first-page":"3706","DOI":"10.3390\/cancers13153706","volume":"13","author":"C Werner","year":"2021","unstructured":"Werner C, Stangl S, Salvermoser L, Schwab M, Shevstov M, Xanthopoulos A, et al. Exosomal HSP70 in liquid biopsies: a biomarker for prediction and response monitoring in cancer. Cancers. 2021;13:3706.","journal-title":"Cancers"},{"key":"851_CR64","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1186\/s12885-025-14725-5","volume":"25","author":"D Lobinger","year":"2025","unstructured":"Lobinger D, Taylor N, Messner V, Seier S, Bodner J, Roberts E, et al. Circulating HSP70: a tumor biomarker for lymph node metastases and early relapse in thoracic cancer. BMC Cancer. 2025;25:1297.","journal-title":"BMC Cancer"},{"key":"851_CR65","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.4149\/neo_2021_210118N81","volume":"68","author":"XJ Qiao","year":"2021","unstructured":"Qiao XJ, Gu Y, Du H, Xing ZW, Ma BH, Sun WT, et al. Co-expression of CD24 and HSP70 as a prognostic biomarker for lung cancer. Neoplasma. 2021;68:1023\u201332.","journal-title":"Neoplasma"},{"key":"851_CR66","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.clbc.2020.11.005","volume":"21","author":"HH Fahim","year":"2021","unstructured":"Fahim HH, Mohamed G, Safwat G, Abo-bakr A, Ibraheem MH, Al-Mofty S, et al. HSP70 as a diagnostic and prognostic marker in Egyptian women with breast cancer. Clin Breast Cancer. 2021;21:177\u201388.","journal-title":"Clin Breast Cancer"},{"key":"851_CR67","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1097\/MPA.0b013e3182374ace","volume":"41","author":"SK Dutta","year":"2012","unstructured":"Dutta SK, Girotra M, Singla M, Dutta A, Stephen FO, Nair PP, et al. Serum HSP70: a novel biomarker for early detection of pancreatic cancer. Pancreas. 2012;41:530\u20134.","journal-title":"Pancreas"},{"key":"851_CR68","first-page":"97","volume":"236","author":"M Gunaldi","year":"2015","unstructured":"Gunaldi M, Afsar CU, Okuturlar Y, Gedikbasi A, Kocoglu H, Kural A, et al. Elevated serum levels of HSP70 are associated with breast cancer. J Exp Med. 2015;236:97\u2013102.","journal-title":"J Exp Med"},{"issue":"19","key":"851_CR69","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s12957-021-02269-4","volume":"4","author":"Y Han","year":"2021","unstructured":"Han Y, Zhang Y, Cui L, Li Z, Feng H, Zhang Y, et al. Plasma heat shock protein 90alpha as a biomarker for the diagnosis of liver cancer: in patients with different clinicopathologic characteristics. World J Surg Oncol. 2021;4(19):228.","journal-title":"World J Surg Oncol."},{"key":"851_CR70","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s12957-021-02269-4","volume":"19","author":"H Yueting","year":"2021","unstructured":"Yueting H, Zhang Y, Cui L, Li Z, Feng H, Zhang Y, et al. Plasma HSP90\u03b1 as a biomarker for the diagnosis of liver cancer in patients with different clinicopathologic characteristics. World J Surg Oncol. 2021;19:228.","journal-title":"World J Surg Oncol."},{"key":"851_CR71","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1080\/15384047.2020.1736482","volume":"21","author":"S Mittal","year":"2020","unstructured":"Mittal S, Rajala MS. Heat shock proteins as biomarkers of lung cancer. Cancer Biol Ther. 2020;21:477\u201385.","journal-title":"Cancer Biol Ther"},{"key":"851_CR72","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1683060","volume":"15","author":"W Zhang","year":"2026","unstructured":"Zhang W, Miao Y, Liu L. Diagnostic value of plasma heat shock protein 90\u03b1 and inflammatory markers in prostate cancer. Front Oncol. 2026;15:1683060.","journal-title":"Front Oncol"},{"key":"851_CR73","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24462","volume":"36","author":"Z Yuan","year":"2022","unstructured":"Yuan Z, Wang L, Hong S, Shi C, Yuan B. Diagnostic value of HSP90\u03b1 and related markers in lung cancer. J Clin Lab Anal. 2022;36:e24462.","journal-title":"J Clin Lab Anal"},{"key":"851_CR74","doi-asserted-by":"publisher","first-page":"3797","DOI":"10.31557\/APJCP.2025.26.10.3797","volume":"26","author":"M Jain","year":"2025","unstructured":"Jain M, Sharma A, Takodara S, Pepineni JK, Mittal R, Chaudhary M. Diagnostic efficacy of HSP90\u03b1, neuron-specific enolase (NSE) and carcinoembryonic antigen (CEA) serum biomarkers in the diagnosis of lung cancer. Asian Pac J Cancer Prev. 2025;26:3797\u2013803.","journal-title":"Asian Pac J Cancer Prev"},{"key":"851_CR75","doi-asserted-by":"publisher","first-page":"5518","DOI":"10.1177\/0300060519865634","volume":"47","author":"S Han","year":"2019","unstructured":"Han S, Cheng Z, Zhao X, Huang Y. Diagnostic value of HSP90\u03b1 and squamous cell carcinoma antigen in detection of cervical cancer. J Int Med Res. 2019;47:5518\u201325.","journal-title":"J Int Med Res"},{"key":"851_CR76","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26209979","volume":"26","author":"I Flores","year":"2025","unstructured":"Flores I, Salazar A, P\u00e9rez de la Cruz V, Mena-Guerrero T, Cossio JA, Figueroa R, et al. Von Hippel\u2013Lindau\/hypoxia inducible factor axis in glioblastoma. Int J Mol Sci. 2025;26:9979.","journal-title":"Int J Mol Sci"},{"key":"851_CR77","first-page":"535","volume":"31","author":"M Assimakopoulou","year":"2016","unstructured":"Assimakopoulou M, Androutsopoulou C, Zolota V, Matsoukas J. Immunoexpression patterns for hypoxia-inducible factor-1\u03b1 and von Hippel\u2013Lindau protein, in relation to HSP90, of human brain tumors. Histol Histopathol. 2016;31:535\u201346.","journal-title":"Histol Histopathol"},{"key":"851_CR78","doi-asserted-by":"publisher","first-page":"3781","DOI":"10.1007\/s12094-025-03901-5","volume":"27","author":"S Buend\u00eda-L\u00f3pez","year":"2025","unstructured":"Buend\u00eda-L\u00f3pez S, Rubio-San-Sim\u00f3n A, Wu JH, Azor\u00edn-Cuadrillero D, Sanz-Miguel A, Lassaletta \u00c1, et al. A comprehensive clinico-pathological review of a series of pediatric, adolescents and young adults with high-grade osteosarcoma: from clinics to biomarker discovery. Clin Transl Oncol. 2025;27:3781\u201392.","journal-title":"Clin Transl Oncol"},{"key":"851_CR79","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2174\/0115748871317252240919051309","volume":"20","author":"K Tzelepis","year":"2024","unstructured":"Tzelepis K, Giannakodimos I, Politis V, Stamatiou K, Provatas I, Mitakidi E, et al. Expression of HSP90 in testicular cancer: a retrospective cohort study. Rev Recent Clin Trials. 2024;20:153\u20139.","journal-title":"Rev Recent Clin Trials"},{"key":"851_CR80","doi-asserted-by":"publisher","first-page":"693","DOI":"10.7754\/Clin.Lab.2024.241043","volume":"71","author":"WY Qin","year":"2025","unstructured":"Qin WY, Ma MM, Wang BF, Deng J. The correlation between serum HSP90\u03b1 and the diagnosis and classification of acute myeloid leukaemia in children. Clin Lab. 2025;71:693\u20139.","journal-title":"Clin Lab"},{"key":"851_CR81","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1080\/17474086.2025.2574713","volume":"19","author":"RA Lezama","year":"2025","unstructured":"Lezama RA, Gudino Garcia A, Lopez Ramirez K, Vela Ojeda J, Reyes Maldonado E, Victoria-Avila ZL. Mechanism regulation of endoplasmic reticulum stress in multiple myeloma cells: modulation of the UPR, UPS, autophagy, HSPs and potential therapeutic targets. Expert Rev Hematol. 2025;19:143\u201356.","journal-title":"Expert Rev Hematol"},{"key":"851_CR82","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1177\/15353702221142614","volume":"248","author":"LM Tan","year":"2023","unstructured":"Tan LM, Ke SP, Li X, Ouyang TL, Yu LQ, Yu JL, et al. The value of serum TRAP1 in diagnosing small cell lung cancer and tumor immunity. Exp Biol Med. 2023;248:201\u20138.","journal-title":"Exp Biol Med"},{"key":"851_CR83","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.102658","volume":"14","author":"S Dabsan","year":"2025","unstructured":"Dabsan S, Zur G, Abu-Freha N, Sofer S, Grossman-Haham I, Gilad A, et al. Cytosolic and endoplasmic reticulum chaperones inhibit wt-p53 to increase cancer cells\u2019 survival by refluxing ER-proteins to the cytosol. Elife. 2025;14:e102658.","journal-title":"Elife"},{"key":"851_CR84","doi-asserted-by":"publisher","first-page":"1301690","DOI":"10.1177\/18758592241301690","volume":"42","author":"G Ak","year":"2025","unstructured":"Ak G, Metintas S, Gunes HV, Cosan DT, Kurt H, Yilmaz S, et al. The relationship between serum levels of Grp78, Grp94, calnexin and calreticulin and prognosis in patients with lung cancer. Cancer Biomark. 2025;42:1301690.","journal-title":"Cancer Biomark"},{"key":"851_CR85","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1111\/cas.14143","volume":"110","author":"W Liu","year":"2019","unstructured":"Liu W, Li J, Zhang P, Hou Q, Feng S, Liu L, et al. A novel pan-cancer biomarker HSP90\u03b1 and its diagnosis determinants in clinic. Cancer Sci. 2019;110:2941\u201359.","journal-title":"Cancer Sci"},{"key":"851_CR86","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1042\/BJ20130963","volume":"457","author":"XA Lu","year":"2014","unstructured":"Lu XA, Wang X, Zhuo W, Jia L, Jiang Y, Fu Y, et al. The regulatory mechanism of a client kinase controlling its own release from HSP90 chaperone machinery through phosphorylation. Biochem J. 2014;457:171\u201383.","journal-title":"Biochem J"},{"key":"851_CR87","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.3390\/ijms19092560","volume":"19","author":"A Hoter","year":"2018","unstructured":"Hoter A, El-Sabban ME, Naim HY. The HSP90 family: structure, regulation, function and implications in health and disease. Int J Mol Sci. 2018;19:2560.","journal-title":"Int J Mol Sci"},{"key":"851_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2026.150576","volume":"347","author":"J Kaur","year":"2026","unstructured":"Kaur J, Nautiyal S, Roy I. Aptamer-mediated targeted approach to disrupt oncogenic HSP90\u03b1. Int J Biol Macromol. 2026;347:150576.","journal-title":"Int J Biol Macromol"},{"key":"851_CR89","doi-asserted-by":"publisher","first-page":"8962","DOI":"10.3390\/ijms26188962","volume":"26","author":"MG Amado","year":"2025","unstructured":"Amado MG, Pazos M, Carrera M. Mass spectrometry-based proteomics for seafood allergen detection and quantification: current trends and technological frontiers. Int J Mol Sci. 2025;26:8962.","journal-title":"Int J Mol Sci"},{"key":"851_CR90","doi-asserted-by":"publisher","DOI":"10.1002\/pro.5173","volume":"33","author":"A Javed","year":"2024","unstructured":"Javed A, Johnson OT, Balana AT, Volk RF, Langen A, Ahn BS, et al. O-GlcNAc modification of HSP27 alters its protein interactions and promotes refolding of proteins through the BAG3\/HSP70 co-chaperone. Protein Sci. 2024;33:e5173.","journal-title":"Protein Sci"},{"key":"851_CR91","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3343\/alm.2016.36.4.353","volume":"36","author":"M Zimmermann","year":"2016","unstructured":"Zimmermann M, Traxler D, Simader E, Bekos C, Dieplinger B, Lainscak M, et al. In vitro stability of HSP27 in serum and plasma under different pre-analytical conditions: implications for large-scale clinical studies. Ann Lab Med. 2016;36:353\u20137.","journal-title":"Ann Lab Med"},{"key":"851_CR92","doi-asserted-by":"publisher","first-page":"4709","DOI":"10.1007\/s11033-022-07320-5","volume":"49","author":"S Martire","year":"2022","unstructured":"Martire S, Valentino P, Marnetto F, Mirabile L, Capobianco M, Bertolotto A. The impact of pre-freezing storage time and temperature on gene expression of blood collected in EDTA tubes. Mol Biol Rep. 2022;49:4709\u201318.","journal-title":"Mol Biol Rep"},{"key":"851_CR93","doi-asserted-by":"publisher","first-page":"3915","DOI":"10.1021\/acschemneuro.1c00508","volume":"12","author":"K Vermeulen","year":"2021","unstructured":"Vermeulen K, Cools R, Briard E, Auberson Y, Schoepfer J, Koole M, et al. Preclinical evaluation of [11C]YC-72-AB85 for in vivo visualization of HSP90 in brain and cancer with positron emission tomography. ACS Chem Neurosci. 2021;12:3915\u201327.","journal-title":"ACS Chem Neurosci"},{"key":"851_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.cstres.2025.100105","volume":"30","author":"R Cools","year":"2025","unstructured":"Cools R, Vermeulen K, Bormans G. In vivo imaging of HSP90: diagnostic tool and support for HSP90-targeted therapy. Cell Stress Chaperones. 2025;30:100105.","journal-title":"Cell Stress Chaperones"},{"key":"851_CR95","doi-asserted-by":"publisher","first-page":"829","DOI":"10.3390\/cells11050829","volume":"11","author":"H Zhang","year":"2022","unstructured":"Zhang H, Gong W, Wu S, Perrett S. HSP70 in redox homeostasis. Cells. 2022;11:829.","journal-title":"Cells"},{"key":"851_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2024.108827","volume":"179","author":"A Stefano","year":"2024","unstructured":"Stefano A. Challenges and limitations in applying radiomics to PET imaging: possible opportunities and avenues for research. Comput Biol Med. 2024;179:108827.","journal-title":"Comput Biol Med"},{"key":"851_CR97","doi-asserted-by":"publisher","first-page":"1847197","DOI":"10.1155\/adpp\/1847197","volume":"2025","author":"AA Roy","year":"2025","unstructured":"Roy AA, Pandey A, Dhas N, Hegde MM, Parekh HS, Andugulapati SB, et al. The confluence of nanotechnology and HSP70 in pioneering glioblastoma multiforme therapy: forging pathways towards precision targeting and transformation. Adv Pharmacol Pharm Sci. 2025;2025:1847197.","journal-title":"Adv Pharmacol Pharm Sci."},{"key":"851_CR98","doi-asserted-by":"publisher","DOI":"10.1016\/j.nucmedbio.2024.108929","volume":"136","author":"F Li","year":"2024","unstructured":"Li F, Fan Y, Zhou L, Martin DR, Liu Z, Li Z. Synthesis and characterization of 64Cu-labeled geldanamycin derivative for imaging HSP90 expression in breast cancer. Nucl Med Biol. 2024;136:108929.","journal-title":"Nucl Med Biol"},{"key":"851_CR99","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s41181-025-00331-0","volume":"10","author":"V Narykina","year":"2025","unstructured":"Narykina V, Kleynhans J, Cawthorn C, Schymkowitz J, Rousseau F, Bormans G. Development and evaluation of HSP90-targeting nanobodies for visualisation of extracellular HSP90 in tumors using PET imaging. EJNMMI Radiopharm Chem. 2025;10:10.","journal-title":"EJNMMI Radiopharm Chem."},{"key":"851_CR100","doi-asserted-by":"publisher","first-page":"554","DOI":"10.7150\/thno.27213","volume":"9","author":"K Vermeulen","year":"2019","unstructured":"Vermeulen K, Naus E, Ahamed M, Attili B, Siemons M, Luyten K, et al. Evaluation of [11C]NMS-E973 as a PET tracer for in vivo visualisation of HSP90. Theranostics. 2019;9:554\u201372.","journal-title":"Theranostics."},{"key":"851_CR101","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ebiom.2017.09.007","volume":"24","author":"Y Fu","year":"2017","unstructured":"Fu Y, Xu X, Huang D, Cui D, Liu L, Liu J, et al. Plasma HSP90\u03b1 as a biomarker for the diagnosis of liver cancer: an official, large-scale and multicenter clinical trial. EBioMedicine. 2017;24:56\u201363.","journal-title":"EBioMedicine"},{"key":"851_CR102","doi-asserted-by":"publisher","first-page":"6016","DOI":"10.1158\/1078-0432.CCR-14-0174","volume":"20","author":"Y Shi","year":"2014","unstructured":"Shi Y, Liu X, Lou J, Han X, Zhang L, Wang Q, et al. Plasma levels of HSP90\u03b1 associated with lung cancer development and treatment responses. Clin Cancer Res. 2014;20:6016\u201322.","journal-title":"Clin Cancer Res"},{"key":"851_CR103","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1007\/s12072-022-10391-y","volume":"16","author":"K Su","year":"2022","unstructured":"Su K, Liu Y, Wang P, He K, Wang F, Chi H, et al. HSP90\u03b1 is a potential prognostic and predictive biomarker in hepatocellular carcinoma: a large-scale and multicenter study. Hepatol Int. 2022;16:1208\u201319.","journal-title":"Hepatol Int"},{"key":"851_CR104","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.107145","volume":"90","author":"XQ Liang","year":"2021","unstructured":"Liang XQ, Li KZ, Li Z, Xie MZ, Tang YP, Du JB, et al. Diagnostic and prognostic value of plasma HSP90 alpha in gastric cancer. Int Immunopharmacol. 2021;90:107145.","journal-title":"Int Immunopharmacol"},{"key":"851_CR105","doi-asserted-by":"publisher","first-page":"874","DOI":"10.3390\/biom13050874","volume":"13","author":"S Safi","year":"2023","unstructured":"Safi S, Messner L, Kliebisch M, Eggert L, Ceylangil C, Lennartz P, et al. Circulating HSP70 levels and the immunophenotype of peripheral blood lymphocytes as potential biomarkers for advanced lung cancer and therapy failure after surgery. Biomolecules. 2023;13:874.","journal-title":"Biomolecules"},{"key":"851_CR106","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/6184162","volume":"2018","author":"T Tang","year":"2018","unstructured":"Tang T, Yang C, Brown HE, Huang J. Circulating HSP70 is a novel biomarker for early diagnosis of lung cancer. Dis Markers. 2018;2018:6184162.","journal-title":"Dis Markers"},{"key":"851_CR107","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1007\/s11010-024-05089-8","volume":"480","author":"FL Orsatti","year":"2025","unstructured":"Orsatti FL, de Queiroz Freitas AC, Borges AVBE, Santato AS, de Oliveira AC, Souza MVC, et al. Unveiling the role of exercise in modulating plasma HSP27 levels: insights for exercise immunology and cardiovascular health. Mol Cell Biochem. 2025;480:1381\u2013401.","journal-title":"Mol Cell Biochem"},{"key":"851_CR108","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.neuroscience.2009.12.067","volume":"166","author":"B Liebelt","year":"2010","unstructured":"Liebelt B, Papapetrou P, Ali A, Guo M, Ji X, Peng C, et al. Exercise preconditioning reduces neuronal apoptosis in stroke by up-regulating HSP70 (HSP72) and extracellular-signal-regulated-kinase 1\/2. Neuroscience. 2010;166:1091\u2013100.","journal-title":"Neuroscience"},{"key":"851_CR109","doi-asserted-by":"publisher","first-page":"643","DOI":"10.2165\/00007256-200939080-00003","volume":"39","author":"JP Morton","year":"2009","unstructured":"Morton JP, Kayani AC, McArdle A, Drust B. The exercise-induced stress response of skeletal muscle, with specific emphasis on humans. Sports Med. 2009;39:643\u201362.","journal-title":"Sports Med"},{"key":"851_CR110","doi-asserted-by":"publisher","DOI":"10.3390\/ijms221910317","volume":"22","author":"B Birbo","year":"2021","unstructured":"Birbo B, Madu EE, Madu CO, Jain A, Lu Y. Role of HSP90 in cancer. Int J Mol Sci. 2021;22:10317.","journal-title":"Int J Mol Sci"},{"key":"851_CR111","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.1002\/elps.1150181519","volume":"18","author":"L Bini","year":"1997","unstructured":"Bini L, Magi B, Marzocchi B, Arcuri F, Tripodi S, Cintorino M, et al. Protein expression profile in human breast ductal carcinoma and histologically normal tissue. Electrophoresis. 1997;18:2832\u201341.","journal-title":"Electrophoresis"},{"key":"851_CR112","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064378","volume":"8","author":"J D\u00edaz-Ch\u00e1vez","year":"2013","unstructured":"D\u00edaz-Ch\u00e1vez J, Fonseca-S\u00e1nchez MA, Arechaga-Ocampo E, Flores-P\u00e9rez A, Palacios-Rodr\u00edguez Y, Dom\u00ednguez-G\u00f3mez G, et al. Proteomic profiling reveals that resveratrol inhibits HSP27 expression and sensitizes breast cancer cells to doxorubicin therapy. PLoS ONE. 2013;8:e64378.","journal-title":"PLoS ONE"},{"key":"851_CR113","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/bjc.2012.188","volume":"107","author":"B Gibert","year":"2012","unstructured":"Gibert B, Eckel B, Gonin V, Goldschneider D, Fombonne J, Deux B, et al. Targeting HSP27 (HSPB1) interferes with bone metastasis and tumor formation in vivo. Br J Cancer. 2012;107:63\u201370.","journal-title":"Br J Cancer"},{"key":"851_CR114","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s13046-016-0425-9","volume":"35","author":"N Jagadish","year":"2016","unstructured":"Jagadish N, Agarwal S, Gupta N, Fatima R, Devi S, Kumar V, et al. HSP70-2 (HSP72) overexpression in breast cancer. J Exp Clin Cancer Res. 2016;35:150.","journal-title":"J Exp Clin Cancer Res"},{"key":"851_CR115","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcb.2020.151148","volume":"100","author":"A Kotwal","year":"2021","unstructured":"Kotwal A, Suran S, Subbarao SA. HSP90 chaperone facilitates E2F1\/2-dependent gene transcription in human breast cancer cells. Eur J Cell Biol. 2021;100:151148.","journal-title":"Eur J Cell Biol"},{"key":"851_CR116","doi-asserted-by":"publisher","first-page":"20605","DOI":"10.1038\/srep20605","volume":"6","author":"H Dong","year":"2016","unstructured":"Dong H, Zou M, Bhatia A, Jayaprakash P, Hofman F, Ying Q, et al. Breast cancer MDA-MB-231 cells use secreted HSP90\u03b1 to survive a hostile hypoxic environment. Sci Rep. 2016;6:20605.","journal-title":"Sci Rep"},{"key":"851_CR117","doi-asserted-by":"publisher","DOI":"10.1016\/j.cstres.2025.100118","volume":"30","author":"SJ Backe","year":"2025","unstructured":"Backe SJ, Heritz JA, Mollapour M. HSP70 and HSP90 post-translational modifications and translating the chaperone code. Cell Stress Chaperones. 2025;30:100118.","journal-title":"Cell Stress Chaperones"},{"key":"851_CR118","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2025.110519","volume":"301","author":"JA Heritz","year":"2025","unstructured":"Heritz JA, Meluni KA, Backe SJ, Cayaban SJ, Wengert LA, Kunz M, et al. Integrating deep learning for post-translational modifications crosstalk on HSP90 and drug binding. J Biol Chem. 2025;301:110519.","journal-title":"J Biol Chem"},{"key":"851_CR119","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/S0140-6736(95)90090-X","volume":"345","author":"SE Conroy","year":"1995","unstructured":"Conroy SE, Gibson SL, Brunstr\u00f6m G, Isenberg D, Luqmani Y, Latchman DS. Autoantibodies to 90 kD heat-shock protein in sera of breast cancer patients. Lancet. 1995;345:126.","journal-title":"Lancet"},{"key":"851_CR120","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1111\/j.1349-7006.2001.tb01097.x","volume":"92","author":"M Oka","year":"2001","unstructured":"Oka M, Sato SI, Soda H, Fukuda M, Kawabata S, Nakatomi K, et al. Autoantibody to HSP40 in sera of lung cancer patients. Jpn J Cancer Res. 2001;92:316\u201320.","journal-title":"Jpn J Cancer Res"},{"key":"851_CR121","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3233\/CBM-160117","volume":"18","author":"L Shi","year":"2017","unstructured":"Shi L, Chevolot Y, Souteyrand E, Laurenceau E. Autoantibodies against heat shock proteins as biomarkers for the diagnosis and prognosis of cancer. Cancer Biomark. 2017;18:105\u201316.","journal-title":"Cancer Biomark"},{"key":"851_CR122","doi-asserted-by":"publisher","first-page":"677","DOI":"10.5483\/BMBRep.2012.45.12.236","volume":"45","author":"CK Heo","year":"2012","unstructured":"Heo CK, Bahk YY, Cho EW. Tumor-associated autoantibodies as diagnostic and prognostic biomarkers. BMB Rep. 2012;45:677\u201385.","journal-title":"BMB Rep"},{"key":"851_CR123","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1038\/s41416-025-03215-x","volume":"133","author":"K Wang","year":"2025","unstructured":"Wang K, Xiong W, Duan X, Li Q, Ren P, Ye H, et al. A nomogram based on autoantibodies for noninvasive detection of AFP-negative hepatocellular carcinoma: a multicenter study. Br J Cancer. 2025;133:1896\u2013906.","journal-title":"Br J Cancer"},{"key":"851_CR124","doi-asserted-by":"publisher","DOI":"10.1002\/pro.70199","volume":"34","author":"C Sroge","year":"2025","unstructured":"Sroge C, Suk J, Zhu J, Padilla MS, Baca CF, Butts CT, et al. Mini-\u03b1A-crystallin protects a client lens protein from catastrophic aggregation due to heat stress. Protein Sci. 2025;34:70199.","journal-title":"Protein Sci"},{"key":"851_CR125","doi-asserted-by":"publisher","DOI":"10.1177\/00368504251343177","volume":"108","author":"Y Yuan","year":"2025","unstructured":"Yuan Y, Zhang X, Xu Y, Ge Y, Wu A. \u03b1B-crystallin enhances radioresistance in basal-like breast cancer cells by suppressing caspase-3 activation. Sci Prog. 2025;108:43177.","journal-title":"Sci Prog"},{"key":"851_CR126","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1080\/15548627.2024.2447206","volume":"21","author":"H Shen","year":"2025","unstructured":"Shen H, Xie Y, Wang Y, Xie Y, Wang Y, Su Z, et al. The ER protein CANX (calnexin)-mediated autophagy protects against Alzheimer\u2019s disease. Autophagy. 2025;21:1096\u2013115.","journal-title":"Autophagy"},{"key":"851_CR127","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2025.118122","volume":"300","author":"Q Yin","year":"2025","unstructured":"Yin Q, Song Q, Sun L, Lu J, Zhang X. Targeting calreticulin (CALR) in tumors: cellular mechanisms, structural insights and ligand development advances. Eur J Med Chem. 2025;300:118122.","journal-title":"Eur J Med Chem"},{"key":"851_CR128","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25126452","volume":"25","author":"A Miura","year":"2024","unstructured":"Miura A, Narita Y, Sugawara T, Shimizu H, Itoh H. Mizoribine promotes molecular chaperone HSP60\/HSP10 complex formation. Int J Mol Sci. 2024;25:6452.","journal-title":"Int J Mol Sci"},{"key":"851_CR129","doi-asserted-by":"publisher","DOI":"10.1186\/s40659-025-00591-9","volume":"58","author":"A Szewczyk","year":"2025","unstructured":"Szewczyk A, Rembia\u0142kowska N, Saczko J, Daczewska M, Novickij V, Kulbacka J. Calcium electroporation induces stress response through upregulation of HSP27, HSP70, aspartate \u03b2-hydroxylase and CD133 in human colon cancer cells. Biol Res. 2025;58:10.","journal-title":"Biol Res"},{"key":"851_CR130","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1080\/14728222.2021.1861249","volume":"25","author":"PS Bellaye","year":"2021","unstructured":"Bellaye PS, Burgy O, Bonniaud P, Kolb M. HSP47: a potential target for fibrotic diseases and implications for therapy. Expert Opin Ther Targets. 2021;25:49\u201362.","journal-title":"Expert Opin Ther Targets"},{"key":"851_CR131","doi-asserted-by":"publisher","DOI":"10.1172\/JCI149906","volume":"132","author":"R Kumar","year":"2022","unstructured":"Kumar R, Chaudhary AK, Woytash J, Inigo JR, Gokhale AA, Bshara W, et al. A mitochondrial unfolded protein response inhibitor suppresses prostate cancer growth in mice via HSP60. J Clin Investig. 2022;132:149906.","journal-title":"J Clin Investig"},{"key":"851_CR132","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.tcb.2018.10.004","volume":"29","author":"TM Luengo","year":"2019","unstructured":"Luengo TM, Mayer MP, R\u00fcdiger SG. The HSP70\u2013HSP90 chaperone cascade in protein folding. Trends Cell Biol. 2019;29:164\u201377.","journal-title":"Trends Cell Biol"},{"key":"851_CR133","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12032-024-02586-0","volume":"42","author":"M Lin","year":"2025","unstructured":"Lin M, Mo Y, Li CM, Liu YZ, Feng XP. Grp78 as a potential therapeutic target in cancer treatment: an updated review of its role in chemoradiotherapy resistance of cancer cells. Med Oncol. 2025;42:1\u201321.","journal-title":"Med Oncol"},{"key":"851_CR134","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.629846","volume":"11","author":"X Duan","year":"2021","unstructured":"Duan X, Iwanowycz S, Ngoi S, Hill M, Zhao Q, Liu B. Molecular chaperone Grp94\/Gp96 in cancers: oncogenesis and therapeutic target. Front Oncol. 2021;11:629846.","journal-title":"Front Oncol"},{"key":"851_CR135","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1152\/ajprenal.00192.2024","volume":"328","author":"AW Porter","year":"2025","unstructured":"Porter AW, Vorndran HE, Marciszyn A, Mutchler SM, Subramanya AR, Kleyman TR, et al. Excess dietary sodium restores electrolyte and water homeostasis caused by loss of the endoplasmic reticulum molecular chaperone, Grp170, in the mouse nephron. Am J Physiol Ren Physiol. 2025;328:173\u201389.","journal-title":"Am J Physiol Ren Physiol."},{"key":"851_CR136","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1002\/med.22114","volume":"45","author":"S Chaudhury","year":"2025","unstructured":"Chaudhury S, D\u2032Amico T, Blagg BS. The HSP90\u03b2 isoform: an attractive target for drug development. Med Res Rev. 2025;45:1452\u201365.","journal-title":"Med Res Rev"},{"key":"851_CR137","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.115005","volume":"43","author":"JB Lin","year":"2024","unstructured":"Lin JB, Carman PJ, Gambogi CW, Kendsersky NM, Chuang E, Gates SN, et al. Design principles to tailor HSP104 therapeutics. Cell Rep. 2024;43:115005.","journal-title":"Cell Rep"},{"key":"851_CR138","doi-asserted-by":"publisher","first-page":"977","DOI":"10.2147\/OTT.S496403","volume":"17","author":"R Guo","year":"2024","unstructured":"Guo R, Wang R, Zhang W, Li Y, Wang Y, Wang H, et al. Mechanisms of action of HSP110 and its cognate family members in carcinogenesis. OncoTargets Ther. 2024;17:977\u201389.","journal-title":"OncoTargets Ther."},{"key":"851_CR139","doi-asserted-by":"publisher","DOI":"10.1007\/s00604-024-06333-0","volume":"191","author":"R Liu","year":"2024","unstructured":"Liu R, Liu Y, Li C, Agyapong DA, Feng J, Tang L, et al. Sensitive detection of HSP70 using a current-amplified biosensor based on antibody-loaded PS-AuNPsCys\/Au modified ITO chip. Mikrochim Acta. 2024;191:272.","journal-title":"Mikrochim Acta"},{"key":"851_CR140","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.bios.2018.03.049","volume":"111","author":"B Sun","year":"2018","unstructured":"Sun B, Cai J, Li W, Gou X, Gou Y, Li D, et al. A novel electrochemical immunosensor based on PG for early screening of depression markers-HSP70. Biosens Bioelectron. 2018;111:34\u201340.","journal-title":"Biosens Bioelectron"},{"key":"851_CR141","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.talanta.2016.07.039","volume":"160","author":"B \u00d6zcan","year":"2016","unstructured":"\u00d6zcan B, Sezgint\u00fcrk MK. Graphene oxide based electrochemical label free immunosensor for rapid and highly sensitive determination of tumor marker HSP70. Talanta. 2016;160:367\u201374.","journal-title":"Talanta"},{"key":"851_CR142","doi-asserted-by":"publisher","first-page":"6228","DOI":"10.1021\/ac401075u","volume":"85","author":"H Lin","year":"2013","unstructured":"Lin H, Liu Y, Huo J, Zhang A, Pan Y, Bai H, et al. Modified enzyme-linked immunosorbent assay strategy using graphene oxide sheets and gold nanoparticles functionalized with different antibody types. Anal Chem. 2013;85:6228\u201332.","journal-title":"Anal Chem"},{"key":"851_CR143","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jtice.2021.09.009","volume":"128","author":"NH Maniya","year":"2021","unstructured":"Maniya NH, Parashar K, Kadam LN, Srivastava DN. Electrochemical detection of HSP70 over cost-effective plastic chip electrode platform. J Taiwan Inst Chem Eng. 2021;128:11\u20139.","journal-title":"J Taiwan Inst Chem Eng"},{"key":"851_CR144","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2025.159860","volume":"505","author":"R Liu","year":"2025","unstructured":"Liu R, Li Y, Liu Y, Wang Y, Si Q, Yakoba Agyapong DA, et al. A highly sensitive and reusable magnetic nano-electrochemical biosensor for the detection of the liver cancer biomarker HSP70. Chem Eng J. 2025;505:159860.","journal-title":"Chem Eng J"},{"key":"851_CR145","doi-asserted-by":"publisher","first-page":"3444","DOI":"10.1039\/D2AN00742H","volume":"147","author":"N Wu","year":"2022","unstructured":"Wu N, Wei Y, Pan L, Yang X, Qi H, Gao Q, et al. Sensitive and rapid determination of HSP70 using lateral flow immunostrips and upconversion nanoparticle fluorescence probes. Analyst. 2022;147:3444\u201350.","journal-title":"Analyst"},{"key":"851_CR146","doi-asserted-by":"publisher","DOI":"10.20964\/2021.05.11","volume":"16","author":"M Pohanka","year":"2021","unstructured":"Pohanka M. HSP60 detection by QCM biosensor and antibody covered gold nanoparticles. Int J Electrochem Sci. 2021;16:210512.","journal-title":"Int J Electrochem Sci"},{"key":"851_CR147","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1021\/acssensors.4c02014","volume":"10","author":"XB Hu","year":"2025","unstructured":"Hu XB, Wang YL, Lv JL, Zheng MY, Ma SH, Cao JT, et al. A chemical redox cycling-based dual-mode biosensor for self-powered photoelectrochemical and colorimetric assay of heat shock protein. ACS Sens. 2025;10:196\u2013203.","journal-title":"ACS Sens"},{"key":"851_CR148","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1081\/IAS-120030525","volume":"25","author":"AK De","year":"2004","unstructured":"De AK, Roach SE. Detection of the soluble HSP27 in human serum by an ELISA. J Immunoass Immunochem. 2004;25:159\u201370.","journal-title":"J Immunoass Immunochem"},{"key":"851_CR149","doi-asserted-by":"publisher","DOI":"10.1016\/j.snb.2024.135592","volume":"409","author":"M Negahdary","year":"2024","unstructured":"Negahdary M, do Lago CL, Gutz IG, Buoro RM, Durazzo M, L\u00facio A. Developing a nanomaterial-based 3D-printed platform: application as a cancer aptasensor via detection of HSP90. Sens Actuators B Chem. 2024;409:135592.","journal-title":"Sens Actuators B Chem"},{"key":"851_CR150","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.snb.2017.10.065","volume":"256","author":"C Sun","year":"2018","unstructured":"Sun C, Zhang M, Fei Q, Wang D, Sun Z, Geng Z, et al. Graphite-like g-C3N4-F127-Au nanosheets used for sensitive monitoring of HSP90. Sens Actuators B: Chem. 2018;256:160\u20136.","journal-title":"Sens Actuators B: Chem"},{"key":"851_CR151","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.talanta.2018.09.010","volume":"191","author":"R Zhai","year":"2019","unstructured":"Zhai R, Gong X, Xie J, Yuan Y, Xu F, Jiang Y, et al. Ultrasensitive analysis of HSP90\u03b1 with antibodies orderly arrayed on a novel type of immunoprobe based on magnetic COFs. Talanta. 2019;191:553\u201360.","journal-title":"Talanta"}],"container-title":["Molecular Diagnosis & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-026-00851-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40291-026-00851-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-026-00851-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T11:36:38Z","timestamp":1782819398000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40291-026-00851-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":151,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["851"],"URL":"https:\/\/doi.org\/10.1007\/s40291-026-00851-8","relation":{},"ISSN":["1177-1062","1179-2000"],"issn-type":[{"value":"1177-1062","type":"print"},{"value":"1179-2000","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]},"assertion":[{"value":"13 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We acknowledge partial financial support from the Department of Biotechnology (BT\/PR\/50633\/MED\/32\/975\/2023).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Prajjwal Kushwaha and Ipsita Roy have no conflicts of interest that are directly relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest\/competing interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"Both authors were involved in drafting and reviewing the manuscript. Both authors have read and approved the final version.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 contributions"}}]}}